Introduction Fatigue is a common problem in PD either in the early or later stage of the
disease. Using resting‐state functional MRI, we investigated the functional correlates of …

Introduction Hypokinetic dysarthria (HD) is a common symptom of Parkinson's disease (PD)
which does not respond well to PD treatments. We investigated acute effects of repetitive …

Mild cognitive impairment (MCI) is an intermediate stage between normal aging and
dementia. Researchers tend to discuss its early state (early MCI, eMCI) due to its high …

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …

Objective Cognitive impairment occurs frequently in Parkinson's disease (PD) and
negatively impacts the patient's quality of life. However, its pathophysiological mechanism …

Alzheimer's disease (AD) is the leading cause of dementia due to neurodegeneration and is
characterized by extracellular senile plaques composed of amyloid β1–42 (Aβ) as well as …

Background: Cognitive impairment in Parkinson's disease (PD) is associated with altered
connectivity of the resting state networks (RSNs). Longitudinal studies in well cognitively …

Dopamine‐replacing therapies are an effective treatment for the motor aspects of
Parkinson's disease. However, its precise effect over the cognitive resting‐state networks is …

Parkinson's disease (PD) affects 2–3% of the population over the age of 65 with loss of
dopaminergic neurons in the substantia nigra impacting the functioning of basal ganglia …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by topological
abnormalities in large-scale functional brain networks, which are commonly analyzed using …